Letters Archives – Treatment Action Group

TAG Public Comments for the AIDS Research Advisory Council (ARAC) Meeting, April 6, 2026: Renewing Funding for the HIV Clinical Trial Networks

April 7, 2026
Adam Ortega

TAG recommends that the AIDS Research Advisory Council (ARAC) endorse NIAID's continued support of a balanced and comprehensive portfolio of basic, clinical, and implementation science — including a funding opportunity to renew its four current networks: the Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG), the International Maternal Pediatric Adolescent AIDS Clinical Trials Network (IMPAACT), the HIV Prevention Trials Network (HPTN), and the HIV Vaccine Trials Network (HVTN) or the updated IBPTN.

This Year, Our Board Saw Firsthand What We Are Up Against

December 29, 2025
Jason Kirk

This year revealed how far this administration is willing to go in undermining public health. The White House refused to recognize World AIDS Day. Global and domestic HIV, TB, and HCV programs were directly threatened, and many were terminated. Senior CDC leaders resigned rather than carry out political firings or oversee the degradation of national vaccine guidance. And in August, a vigilante encouraged by political rhetoric fired nearly 500 rounds into the CDC campus in Atlanta and killed a police officer. The President has still not publicly acknowledged the attack.

Open Letter to Canadian PM Mark Carney and Foreign Affairs Minister Anita Anand

November 4, 2025
Jason Kirk

TAG signed onto this letter sponsored by the HIV Legal Network to Canadian Prime Minister Mark Carney about the importance of strong investments in health and community systems as they reinforce global health security, which in turn keeps everyone safe.

TAG’s Recommendations to NIAID on the Future of the HIV Clinical Trials Networks

October 8, 2025
Jason Kirk

In March 2025, the National Institute of Allergy and Infectious Diseases (NIAID) began soliciting comments on the future of the four Division of AIDS (DAIDS)-sponsored HIV clinical research networks: ACTG, IMPAACT, HPTN, and HVTN.

TAG Comments for the September 2025 Centers for Disease Control and Prevention Meeting on How to Leverage Same-Day Diagnosis and Treatment, Docket No. CDC-2025-0321

September 30, 2025
Jason Kirk

TAG sent this comment to the Centers for Disease Control and Prevention (CDC) September 2025 meeting on how to leverage same-day diagnosis and treatment for hepatitis C.

TAG’s Comments for the September 2025 Meeting of the Advisory Committee on Immunization Practices (Docket No. CDC-2025-0454)

September 14, 2025
Jason Kirk

TAG letter urging the Advisory Committee on Immunization Practices (ACIP) to maintain the recommendation of a universal hepatitis B virus (HBV) birth dose vaccine in the United States.

2025 Comments Delivered at the WHO Director General’s TB Vaccine Accelerator Council

May 20, 2025
Jason Kirk

These are the remarks delivered by Mike Frick, TAG’s TB co-director, who was speaking as a civil society representative, at the 3rd meeting of the WHO Director-General’s TB Vaccine Accelerator Council on May 20, 2025 in Geneva, Switzerland.

Hearing on Biomedical Research – Keeping America’s Edge in Innovation

April 30, 2025
Jason Kirk

Treatment Action Group (TAG) is issuing an urgent call to protect the integrity of biomedical research and public health.

Letter Urging Congress to Reject All Proposals to Cut Medicaid

February 4, 2025
Jason Kirk

TAG was proud to sign on to this 2/3/25 letter created by HIV Health Care Access Working Group (HHCAWG) of the Federal AIDS Policy Partnership (FAPP).

TAG’s Submission to the Office of the High Commissioner for Human Rights (OHCHR)

January 21, 2025
Jason Kirk

TAG submitted this this input for the Office of the High Commissioner on Human Rights (OHCHR), in response to its request for "Inputs for the comprehensive report, incl. new developments, in ensuring access to medicines, vaccines and other health products."